JP Morgan Chase
NMRD

JP Morgan Chase’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

JP Morgan Chase’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12
Closed -$3 – 8102
2023
Q4 		$3 Hold
12
– – ﹤0.01% 7468
2023
Q3 		$4 Hold
12
– – ﹤0.01% 7389
2023
Q2 		$11 Hold
12
– – ﹤0.01% 6815
2023
Q1 		$0 Hold
12
– – ﹤0.01% 7383
2022
Q4 		$0 Hold
12
– – ﹤0.01% 7166
2022
Q3 		$0 Hold
12
– – ﹤0.01% 6993
2022
Q2 		$0 Hold
12
– – ﹤0.01% 7030
2022
Q1 		$0 Hold
12
– – ﹤0.01% 7141
2021
Q4 		$0 Hold
12
– – ﹤0.01% 7074
2021
Q3 		$0 Sell
12
-3,260
-100% -$23.5K ﹤0.01% 6916
2021
Q2 		$34K Sell
3,272
-16,951
-84% -$162K ﹤0.01% 5837
2021
Q1 		$155K Buy
20,223
+901
+5% +$5.96K ﹤0.01% 5251
2020
Q4 		$73K Buy
19,322
+14,279
+283% +$55.1K ﹤0.01% 5066
2020
Q3 		$18K Sell
5,043
-451
-8% -$2.63K ﹤0.01% 5173
2020
Q2 		$51K Buy
+5,494
New +$39.2K ﹤0.01% 4821

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

JP Morgan Chase's NMRD Position: Q1 2024 in Review

JP Morgan Chase sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 12 shares — an estimated $3 sold.

JP Morgan Chase first reported a position in NMRD in Q2 2020 and held it in 15 quarters. The position peaked at $155K in Q1 2021. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • JP Morgan Chase reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 12 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $3.
  • JP Morgan Chase first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • JP Morgan Chase's Nemaura Medical, Inc. Common Stock position peaked at $155K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.